John M. Agaiby

Dr. John M. Agaiby

Family Medicine
10400 75th St, Ste 110, 
Kenosha, WI 
Accepting New Patients
10400 75th St, Ste 110, 
Kenosha, WI 

Overview

John Agaiby is a primary care provider, practicing in Family Medicine in Kenosha, Wisconsin.

His clinical expertise encompasses Facet Joint Syndrome, Maturity Onset Diabetes of the Young, Melorheostosis, and Melorheostosis with Osteopoikilosis.

Dr. Agaiby is board certified in American Board Of Family Medicine. He is actively involved in clinical research, participating in 4 clinical trials. Dr. Agaiby is currently accepting new patients.

Specialties

Family Medicine

Licenses

Family Medicine in WI

Board Certifications

American Board Of Family Medicine

Hospital Affiliations

Aurora Medical Center Kenosha
Aurora St Lukes Medical Center

Languages Spoken

English
Arabic

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Common Ground Healthcare
  • OTHER COMMERCIAL
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 26 Less Insurance Carriers -

Locations

Aurora Family Medicine
10400 75th St, Ste 110, Kenosha, WI 53142

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Expertise in
111
conditions
Dr. Kamran K. Ayub
Family Medicine
Expertise in
111
conditions
Dr. Kamran K. Ayub
Family Medicine
Before you request

GI Partners Of Illinois, LLC

9921 Southwest Hwy, 
Oak Lawn, IL 
 (59.9 miles away)
708-499-5678
Languages Spoken:
English, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Kamran Ayub is a primary care provider, practicing in Family Medicine in Oak Lawn, Illinois. Dr. Ayub is highly rated in 111 conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Gallstones, Watermelon Stomach, Endoscopy, and Colonoscopy. Dr. Ayub is board certified in American Board Of Internal Medicine, Gastroenterology. Dr. Ayub is currently accepting new patients.

Expertise in
164
conditions
Expertise in
164
conditions
Before you request

Family Medicine Specialists S.C.

431 W Liberty St, 
Wauconda, IL 
 (24.1 miles away)
815-678-4181
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jennifer Bellucci-Jackson is a primary care provider, practicing in Family Medicine in Wauconda, Illinois. Dr. Bellucci-Jackson is highly rated in 164 conditions, according to our data. Her clinical expertise encompasses Generalized Anxiety Disorder (GAD), Type 2 Diabetes (T2D), Sinusitis, and Empyema. Dr. Bellucci-Jackson is currently accepting new patients.

Expertise in
21
conditions
Dr. Omar B. Saeed
Family Medicine
Expertise in
21
conditions
Dr. Omar B. Saeed
Family Medicine

Saeed Medical Group LTD.

4332 N Elston Ave, 
Chicago, IL 
 (43.5 miles away)
773-754-3500
Languages Spoken:
English, Arabic, Hindi, Spanish, Urdu
See accepted insurances
Accepting New Patients

Omar Saeed is a primary care provider, practicing in Family Medicine in Chicago, Illinois. Dr. Saeed is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Heart Failure, Stroke, Angiodysplasia of the Colon, Heart Transplant, and Lung Transplant. Dr. Saeed is currently accepting new patients.

Frequently Asked Questions about Dr. John M. Agaiby

How do I make an appointment with Dr. John M. Agaiby?

You can book an appointment with Dr. John M. Agaiby by calling their office at 262-948-6839. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John M. Agaiby a top-rated expert for Facet Joint Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John M. Agaiby is classified as an Experienced expert for Facet Joint Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John M. Agaiby specialize in?

While Dr. John M. Agaiby is a Family Medicine, they have specific expertise in Facet Joint Syndrome, Maturity Onset Diabetes of the Young, and Melorheostosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. John M. Agaiby accept my insurance?

Dr. John M. Agaiby accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 262-948-6839 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Agaiby's expertise for a condition
ConditionClose
        View All 29 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile